Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
5405 | 1627 | 31.4 | 77% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
29 | 3 | HIV//VIROLOGY//HIV 1 | 108954 |
773 | 2 | EFAVIRENZ//NEVIRAPINE//RALTEGRAVIR | 12242 |
5405 | 1 | ZIDOVUDINE//DIDANOSINE//ZALCITABINE | 1627 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ZIDOVUDINE | authKW | 575255 | 11% | 17% | 176 |
2 | DIDANOSINE | authKW | 343896 | 4% | 26% | 71 |
3 | ZALCITABINE | authKW | 168231 | 1% | 39% | 23 |
4 | DIDEOXYINOSINE | authKW | 147115 | 1% | 56% | 14 |
5 | 2 3 DIDEOXYINOSINE | authKW | 117271 | 1% | 42% | 15 |
6 | AZT | authKW | 110463 | 3% | 13% | 47 |
7 | AZIDOTHYMIDINE | authKW | 84065 | 1% | 20% | 22 |
8 | ZIDOVUDINE RESISTANCE | authKW | 83590 | 0% | 64% | 7 |
9 | 6 CHLORO 2 3 DIDEOXYGUANOSINE | authKW | 75065 | 0% | 100% | 4 |
10 | DDI | authKW | 59285 | 1% | 20% | 16 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Infectious Diseases | 11142 | 25% | 0% | 406 |
2 | Pharmacology & Pharmacy | 6838 | 39% | 0% | 627 |
3 | Virology | 5066 | 14% | 0% | 224 |
4 | Immunology | 3292 | 23% | 0% | 369 |
5 | Microbiology | 1849 | 15% | 0% | 247 |
6 | Medicine, General & Internal | 980 | 13% | 0% | 207 |
7 | Hematology | 114 | 3% | 0% | 55 |
8 | Toxicology | 94 | 3% | 0% | 50 |
9 | Medicine, Research & Experimental | 75 | 4% | 0% | 61 |
10 | Medical Laboratory Technology | 63 | 1% | 0% | 21 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC TREATMENT CLIN ONCOL PROGRAM | 42222 | 0% | 75% | 3 |
2 | RADIAT THERMAL BIOL | 37532 | 0% | 100% | 2 |
3 | ROOM 5B22 | 25020 | 0% | 67% | 2 |
4 | MED M862 | 24125 | 0% | 43% | 3 |
5 | AIDS CLIN PHARMACOL | 18766 | 0% | 100% | 1 |
6 | AIDS CLIN TRIALS PROGRAM | 18766 | 0% | 100% | 1 |
7 | BAMBIN GESU HOSP | 18766 | 0% | 100% | 1 |
8 | BIOCONVERSEIO | 18766 | 0% | 100% | 1 |
9 | CANC TREATMENTDEV THER EUT PROGRAMBLDG 37 | 18766 | 0% | 100% | 1 |
10 | CHILDERNS INFECT DIS CLIN UNIT | 18766 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 41086 | 3% | 5% | 45 |
2 | JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 23678 | 3% | 3% | 47 |
3 | ANTIVIRAL CHEMISTRY & CHEMOTHERAPY | 20011 | 1% | 5% | 23 |
4 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 9667 | 7% | 0% | 111 |
5 | AIDS | 8033 | 4% | 1% | 61 |
6 | AIDS RESEARCH AND HUMAN RETROVIRUSES | 6429 | 3% | 1% | 43 |
7 | JOURNAL OF INFECTIOUS DISEASES | 3752 | 4% | 0% | 60 |
8 | ANTIVIRAL RESEARCH | 3081 | 1% | 1% | 24 |
9 | ANTIVIRAL THERAPY | 2867 | 1% | 1% | 17 |
10 | DRUG METABOLISM AND DISPOSITION | 2353 | 2% | 0% | 31 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ZIDOVUDINE | 575255 | 11% | 17% | 176 | Search ZIDOVUDINE | Search ZIDOVUDINE |
2 | DIDANOSINE | 343896 | 4% | 26% | 71 | Search DIDANOSINE | Search DIDANOSINE |
3 | ZALCITABINE | 168231 | 1% | 39% | 23 | Search ZALCITABINE | Search ZALCITABINE |
4 | DIDEOXYINOSINE | 147115 | 1% | 56% | 14 | Search DIDEOXYINOSINE | Search DIDEOXYINOSINE |
5 | 2 3 DIDEOXYINOSINE | 117271 | 1% | 42% | 15 | Search 2+3+DIDEOXYINOSINE | Search 2+3+DIDEOXYINOSINE |
6 | AZT | 110463 | 3% | 13% | 47 | Search AZT | Search AZT |
7 | AZIDOTHYMIDINE | 84065 | 1% | 20% | 22 | Search AZIDOTHYMIDINE | Search AZIDOTHYMIDINE |
8 | ZIDOVUDINE RESISTANCE | 83590 | 0% | 64% | 7 | Search ZIDOVUDINE+RESISTANCE | Search ZIDOVUDINE+RESISTANCE |
9 | 6 CHLORO 2 3 DIDEOXYGUANOSINE | 75065 | 0% | 100% | 4 | Search 6+CHLORO+2+3+DIDEOXYGUANOSINE | Search 6+CHLORO+2+3+DIDEOXYGUANOSINE |
10 | DDI | 59285 | 1% | 20% | 16 | Search DDI | Search DDI |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | WILDE, MI , LANGTRY, HD , (1993) ZIDOVUDINE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC EFFICACY.DRUGS. VOL. 46. ISSUE 3. P. 515-578 | 134 | 53% | 85 |
2 | PERRY, CM , BALFOUR, JA , (1996) DIDANOSINE - AN UPDATE ON ITS ANTIVIRAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC EFFICACY IN THE MANAGEMENT OF HIV DISEASE.DRUGS. VOL. 52. ISSUE 6. P. 928 -962 | 95 | 67% | 50 |
3 | STRETCHER, B , (1994) MANAGEMENT OF ANTIRETROVIRAL DRUG-THERAPY IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION.CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES. VOL. 31. ISSUE 2. P. 169-196 | 96 | 74% | 3 |
4 | DUDLEY, MN , (1995) CLINICAL PHARMACOKINETICS OF NUCLEOSIDE ANTIRETROVIRAL AGENTS.JOURNAL OF INFECTIOUS DISEASES. VOL. 171. ISSUE . P. S99-S112 | 73 | 85% | 37 |
5 | STRETCHER, BN , (1995) PHARMACOKINETIC OPTIMIZATION OF ANTIRETROVIRAL THERAPY IN PATIENTS WITH HIV-INFECTION.CLINICAL PHARMACOKINETICS. VOL. 29. ISSUE 1. P. 46-65 | 78 | 66% | 14 |
6 | HOETELMANS, LMW , BURGER, DM , MEENHORST, PL , BEIJNEN, JH , (1996) PHARMACOKINETIC INDIVIDUALISATION OF ZIDOVUDINE THERAPY - CURRENT STATE OF PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS.CLINICAL PHARMACOKINETICS. VOL. 30. ISSUE 4. P. 314-327 | 61 | 74% | 18 |
7 | MCLEOD, GX , HAMMER, SM , (1992) ZIDOVUDINE - 5 YEARS LATER.ANNALS OF INTERNAL MEDICINE. VOL. 117. ISSUE 6. P. 487-501 | 86 | 54% | 110 |
8 | LI, XL , CHAN, WK , (1999) TRANSPORT, METABOLISM AND ELIMINATION MECHANISMS OF ANTI-HIV AGENTS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 39. ISSUE 1-3. P. 81-103 | 84 | 41% | 51 |
9 | ADKINS, JC , PETERS, DH , FAULDS, D , (1997) ZALCITABINE - AN UPDATE OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES AND CLINICAL EFFICACY IN THE MANAGEMENT OF HIV INFECTION.DRUGS. VOL. 53. ISSUE 6. P. 1054 -1080 | 63 | 54% | 25 |
10 | STEIN, DS , MOORE, KHP , (2001) PHOSPHORYLATION OF NUCLEOSIDE ANALOG ANTIRETROVIRALS: A REVIEW FOR CLINICIANS.PHARMACOTHERAPY. VOL. 21. ISSUE 1. P. 11 -34 | 66 | 40% | 67 |
Classes with closest relation at Level 1 |